NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for non-steroidal anti-inflammatory drug


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Advances in malaria research show promise for fight against 1 of the world's deadliest diseases
2009 NOV 29 ... tools like insecticide treated bed nets and an effective anti-malarial combination drug based on artemisinin, has helped the fight."Malaria control and possible ...
Subject: Burness Communications
View Free
Daily News
Article
Inhibitex Reports Third Quarter 2009 Financial Results
2009 NOV 28 ... of ongoing GLP studies, believe we are on track to file an investigational new drug application and initiate a Phase I clinical trial of INX-189 in the first half of ...
Subject: Inhibitex, Inc.
Price: $3.00
*
New Church of Scientology Grand Opening in Washington, DC
2009 NOV 26 ... world over who have given of their time and effort to make the Church's anti-drug education initiative the largest non-governmental program of its kind and the Church's ...
Subject: The Founding Church of Scientology of Washington, Dc
Price: $3.00
*
Scientists at University of Colorado publish research in arthritis
2009 NOV 23 ... 9JR, England. Keywords: State:CO, Country:United States, Abatacept, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Anticancer Therapy, Arthritis, ...
Subject: Arthritis
Price: $3.00
*
Scientists at University of Liege release new data on drug resistance
2009 NOV 23 ... Country:Belgium, Antibacterial, Antibiotic, Antimicrobial Resistance, Carboxypeptidase, Drug Resistance, Enzymes, Medicinal Chemistry, Protease, Therapy, Treatment, University of ...
Subject: Drug Resistance
Price: $3.00
*
Studies from Hospital for Special Surgery, Surgery Department yield new information about arthroplasty
2009 NOV 23 ... cases of infected THAs from 1989 to 2003 were reviewed for data on organism, presence of drug resistance, use of an antibiotic-impregnated spacer, type of reimplant, and success of ...
Subject: Arthroplasty
Price: $3.00
*
Studies from M.B. Jimenez and colleagues provide new data on irritable bowel syndrome
2009 NOV 23 ... the intestinal tract. The disorder is difficult to treat, and the wide spectrum of non-drug and drug treatments shows our ignorance about the cause of the condition. Newer drugs, ...
Subject: Irritable Bowel Syndrome
Price: $3.00
*
Studies from S. Nalmas and co-authors have provided new information about life sciences
2009 NOV 23 ... (14.5%) had human immunodeficiency virus (HIV) infection, and 13 (9.4%) were intravenous drug users. Common SSTA sites involved were the perineal area (43; 31.2%), upper extremities ...
Subject: Life Sciences
Price: $3.00
*
Studies from S.H. Cui et al provide new data on drug resistance
2009 NOV 23 ... Republic of China, Antimicrobial Resistance, Antimicrobials, Chemotherapy, Clindamycin, Drug Resistance, Drug Therapy, Staphylococcus Infections, Therapy, Treatment. ...
Subject: Drug Resistance
Price: $3.00
*
Studies from University of London, Imperial College have provided new data on drug resistance
2009 NOV 23 ... Country:United Kingdom, Antibacterial, Antibiotic, Antimicrobial Resistance, Drug Resistance, Endourology, Surgery, Therapy, Treatment, University of London, Imperial ...
Subject: Drug Resistance
Price: $3.00
*
Studies from University of Utah have provided new information about ovarian cancer
2009 NOV 23 ... skin-fold dorsal window chamber model was applied for visualization of extravasation and drug retention for the initial one hour after iv injection. Noninvasive imaging followed, ...
Subject: Ovarian Cancer
Price: $3.00
*
Studies from Weizmann Institute of Science, Department of Immunology further understanding of multiple sclerosis therapy
2009 NOV 23 ... an approved drug for the treatment of multiple sclerosis, was shown earlier to act as an anti-inflammatory and immunomodulatory agent. In this mini-review its effect on neuroprotection, ...
Subject: Multiple Sclerosis Therapy
Price: $3.00
*
Study data from D.W. Hilbert et al provide new insights into Escherichia coli therapy
2009 NOV 23 ... Antimicrobial Resistance, Antimicrobials, Clinical Microbiology, Diagnosis, Diagnostics, Drug Resistance, Enzymes, Escherichia coli, Gynecology, Infectious Diseases, Polymerase, ...
Subject: Escherichia coli Therapy
Price: $3.00
*
Study findings from Monash University broaden understanding of life sciences
2009 NOV 23 ... Keywords: City:Clayton, Country:Australia, Life Sciences, Antimicrobial Resistance, Drug Resistance, Therapy, Treatment, Clostridium, Antibiotic, Antibacterial, Erythromycin, ...
Subject: Life Sciences
Price: $3.00
*
Study findings from University of Louisville provide new insights into drug resistance
2009 NOV 23 ... Salmonella by ampicillin-resistant Escherichia coli in the presence of otherwise lethal drug concentrations. Proceedings of the Royal Society B - Biological Sciences, ...
Subject: Drug Resistance
Price: $3.00
*
TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post
2009 NOV 24 ... Dr. Himes managed the design, execution and regulatory submissions of cardiovascular and anti-inflammatory product candidates. Dr. Himes earned her MD at the Medical College of Virginia and her ... TARIS Biomedical, a specialty pharmaceutical company pioneering the field of drug-device convergence for targeted therapies, announced the appointment of Julie Lekstrom ...
Subject: TARIS Biomedical Inc.
Price: $3.00
*
The Boston Globe names Cubist to Globe 100's Top Places to Work '09
2009 NOV 23 ... needs, one in CDAD (Clostridium difficile-associated diarrhea) and the other in multi-drug resistant (MDR) Gram-negative infections. In addition, the Company, in collaboration ...
Subject: Cubist Pharmaceuticals, Inc.
Price: $3.00
*
The Nation's Best Math and Science Students Earn Top High School Honors and Strive for $100,000 Scholarship
2009 NOV 24 ... include: invention of anti-bacterial coatings for medical devices, research of cures for drug-resistant Tuberculosis, exploring zebrafish spines for an inside look at bone growth, ...
Subject: Siemens Foundation
Price: $3.00
*
Trimeris Receives Request from Arigene for Extension of Tender Offer Period
2009 NOV 23 ... dependent on third parties for the sale, marketing and distribution of the Company's drug candidates; the market for HIV therapeutics is very competitive with regular new product ...
Subject: Trimeris, Inc.
Price: $3.00
*
VIVA 2009 Late-Breaking Trials Highlight Advances in Interventional Treatments of Peripheral Arterial Disease
2009 NOV 23 ... Clinical Trials, Hospitals, Pharmaceutical, Radiology, Research, Science, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Anatomy, Angiology, ...
Subject: VIVA Physicians, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login